04 Apr 2019 --- The US Food and Drug Administration (FDA) has announced that it will hold a public hearing next month to discuss developing a regulatory framework for the use of cannabidiol (CBD) in foods and beverages as interest in products derived from Cannabis sativa L. continues to balloon. The move will hopefully contribute to constructing “lawful pathways by which products containing cannabis or cannabis-derived compounds can be marketed,” outgoing FDA Commissioner, Dr. Scott Gottlieb, says in a statement.
